FDA Panel Votes Unanimously in Favor of GW Pharmaceuticals’ Cannabidiol Epilepsy Drug

An FDA advisory panel unanimously voted on April 19th to approve GW Pharmaceuticals’ (GWPH) cannabidiol (CBD) containing drug called Epidiolex. The drug has shown to effectively reduce seizures and showed to have a low risk of side effects. The advisory panel has never voted to recommend approval of a cannabidiol containing drug before.

The Epidiolex drug is designed to treat multiple forms of childhood epilepsy. Epidiolex will treat children by being administered in a syrup-form that contains less than 0.1% of tetrahydrocannabinol (THC).

The FDA is scheduled to make the final decision on the status of Epidiolex by June 27th. If Epidiolex were to receive full FDA approval the drug would be the first cannabis containing drug approved by the FDA.

The U.S. federal government’s law currently has cannabis considered as a substance with zero medicinal value. Approval by the FDA would effectively state that cannabis has clear value as a medicine.

Initially the value for GWPH stock didn’t increase from this advisory panel approval. However, on the 20th the stock opened to a 2.33% increase and has since slowly lost value since market open on the 20th.

FDA Panel Votes Unanimously in Favor of GW Pharmaceuticals’ Cannabidiol Epilepsy Drug

About Cannin.com: Your Marijuana Stocks Resource

Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020.

Use Cannin as your resource for:

Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now.

Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?

Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
108% Backtested since 2012

We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best marijuana stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Hemp Stocks to Buy

FDA Panel Votes Unanimously in Favor of GW Pharmaceuticals’ Cannabidiol Epilepsy Drug